| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |